(In thousands)
|
|
Year Ended December 31,
|
|
|
|
2017
|
|
|
2016
|
|
|
2015
|
|
Net income
|
|
$
|
43,690
|
|
|
$
|
13,842
|
|
|
$
|
7,682
|
|
Other comprehensive income (loss):
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency translation adjustments
|
|
|
3,304
|
|
|
|
(3,837
|
)
|
|
|
(2,363
|
)
|
Comprehensive income
|
|
$
|
46,994
|
|
|
$
|
10,005
|
|
|
$
|
5,319
|
|
See accompanying notes to consolidated financial statements.
F-5
TPI COMPOSITES, INC. AND SUBSIDIARIES
Consolidated Statements of Changes in Stockholders’ Equity (Deficit)
(In thousands)
|
|
Common
|
|
|
Paid-in
|
|
|
Accumulated other comprehensive
|
|
|
Accumulated
|
|
|
Treasury stock,
|
|
|
Total stockholders' equity
|
|
|
|
Shares
|
|
|
Amount
|
|
|
capital
|
|
|
income (loss)
|
|
|
deficit
|
|
|
at cost
|
|
|
(deficit)
|
|
Balance at December 31, 2014
|
|
|
4,238
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
2,338
|
|
|
$
|
(189,431
|
)
|
|
$
|
—
|
|
|
$
|
(187,093
|
)
|
Net income
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
7,682
|
|
|
|
—
|
|
|
|
7,682
|
|
Other comprehensive loss
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
(2,363
|
)
|
|
|
—
|
|
|
|
—
|
|
|
|
(2,363
|
)
|
Redeemable preferred shares fair
value adjustment
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
(9,423
|
)
|
|
|
—
|
|
|
|
(9,423
|
)
|
Balance at December 31, 2015
|
|
|
4,238
|
|
|
|
—
|
|
|
|
—
|
|
|
|
(25
|
)
|
|
|
(191,172
|
)
|
|
|
—
|
|
|
|
(191,197
|
)
|
Net income
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
13,842
|
|
|
|
—
|
|
|
|
13,842
|
|
Other comprehensive loss
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
(3,837
|
)
|
|
|
—
|
|
|
|
—
|
|
|
|
(3,837
|
)
|
Redeemable preferred shares fair
value adjustment
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
(5,471
|
)
|
|
|
—
|
|
|
|
(5,471
|
)
|
Issuance of common stock sold in
initial public offering (IPO), net of
underwriters discount and offering
costs
|
|
|
7,188
|
|
|
|
72
|
|
|
|
67,127
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
67,199
|
|
Conversion of convertible preferred
shares into common stock upon
consummation of IPO
|
|
|
21,110
|
|
|
|
253
|
|
|
|
202,993
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
203,246
|
|
Conversion of subordinated
convertible promissory notes
into common stock upon
consummation of IPO
|
|
|
1,080
|
|
|
|
11
|
|
|
|
11,866
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
11,877
|
|
Conversion of redeemable preferred
share warrants into common stock
upon consummation of IPO
|
|
|
121
|
|
|
|
1
|
|
|
|
1,083
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
1,084
|
|
Share-based compensation expense
|
|
|
—
|
|
|
|
—
|
|
|
|
9,764
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
9,764
|
|
Balance at December 31, 2016
|
|
|
33,737
|
|
|
|
337
|
|
|
|
292,833
|
|
|
|
(3,862
|
)
|
|
|
(182,801
|
)
|
|
|
—
|
|
|
|
106,507
|
|
Cumulative-effect adjustment of the adoption of ASU 2016-09 on January 1, 2017
|
|
|
—
|
|
|
|
—
|
|
|
|
1,072
|
|
|
|
—
|
|
|
|
(1,086
|
)
|
|
|
—
|
|
|
|
(14
|
)
|
Net income
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
43,690
|
|
|
|
—
|
|
|
|
43,690
|
|
Other comprehensive income
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
3,304
|
|
|
|
—
|
|
|
|
—
|
|
|
|
3,304
|
|
Common stock repurchased
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
(1,264
|
)
|
|
|
(1,264
|
)
|
Issuances under share-based compensation plan
|
|
|
312
|
|
|
|
3
|
|
|
|
674
|
|
|
|
—
|
|
|
|
—
|
|
|
|
753
|
|
|
|
1,430
|
|
Share-based compensation expense
|
|
|
—
|
|
|
|
—
|
|
|
|
6,964
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
6,964
|
|
Balance at December 31, 2017
|
|
|
34,049
|
|
|
$
|
340
|
|
|
$
|
301,543
|
|
|
$
|
(558
|
)
|
|
$
|
(140,197
|
)
|
|
$
|
(511
|
)
|
|
$
|
160,617
|
|
See accompanying notes to consolidated financial statements.
F-6
TPI COMPOSITES, INC. AND SUBSIDIARIES
Consolidated Statements of Cash Flows
Dostları ilə paylaş: |